Source guides · 23
- Practical Steps: Using Electroconvulsive Therapy in Patients With Neurodevelopmental Disorders and Catatonia. · Full Atlas view
- Practical and Legal Challenges to Electroconvulsive Therapy in Malignant Catatonia. · Full Atlas view
- Practical and Legal Challenges to Electroconvulsive Therapy in Malignant Catatonia. · Full Atlas view
- Prader-Willi syndrome: atypical psychoses and motor dysfunctions. · Full Atlas view
- Pragmatic Trial of Psilocybin Therapy in Palliative Care · Full Atlas view
- Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD) · Full Atlas view
- Predictors of Intravenous Ketamine Response in TRD · Full Atlas view
- Predictors of Postictal Delirium Following Electroconvulsive Therapy in a Sample of Patients With Schizophrenia: An Egyptian Experience. · Full Atlas view
- Pregabalin in an Older Adult Man With Treatment-Resistant Catatonia: A Case Report. · Full Atlas view
- Pregabalin in an Older Adult Man With Treatment-Resistant Catatonia: A Case Report. · Full Atlas view
- Pregnancy and malignant catatonia. · Full Atlas view
- Pregnancy and malignant catatonia. · Full Atlas view
- Preliminary Effectiveness of Hybrid Individual and Group MDMA-assisted Therapy for War-related PTSD · Full Atlas view
- Preoperative Ketamine and Perioperative Depression · Full Atlas view
- Presentation of Delirium-Catatonia in a Patient With Chronic Recreational Nitrous Oxide Use. · Full Atlas view
- Presentation of Delirium-Catatonia in a Patient With Chronic Recreational Nitrous Oxide Use. · Full Atlas view
- Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis. · Full Atlas view
- Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis. · Full Atlas view
- Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis. · Full Atlas view
- Prevalence, Phenotypic Correlates and Predictive Factors of Catatonia in Adolescents With Autism Spectrum Disorder. · Full Atlas view
- Prevalence, Phenotypic Correlates and Predictive Factors of Catatonia in Adolescents With Autism Spectrum Disorder. · Full Atlas view
- Prevalence, Phenotypic Correlates and Predictive Factors of Catatonia in Adolescents With Autism Spectrum Disorder. · Full Atlas view
- Preventing common medical complications of catatonia · Full Atlas view
- Probable Autoimmune Encephalitis Presenting With Catatonia in a Young Woman: A Case Report and Review of the Literature. · Full Atlas view
- Profound Tacrolimus-Induced Catatonic Encephalopathy in a Kidney Transplant Recipient With Mitochondrial Myopathy: A Cautionary Case of Reversible Neurotoxicity. · Full Atlas view
- Profound Tacrolimus-Induced Catatonic Encephalopathy in a Kidney Transplant Recipient With Mitochondrial Myopathy: A Cautionary Case of Reversible Neurotoxicity. · Full Atlas view
- Prognostic Implications of Catatonia in End-of-Life Care for Patients With Advanced Neurocognitive Disorder. · Full Atlas view
- Prognostic Implications of Catatonia in End-of-Life Care for Patients With Advanced Neurocognitive Disorder. · Full Atlas view
- Progressive catatonia. · Full Atlas view
- Progressive catatonia. · Full Atlas view
- Prolonged Catatonia and Severe Malnutrition in Adolescents Following Bullying-Triggered Stress: A Dual Case Report. · Full Atlas view
- Prolonged Catatonia and Severe Malnutrition in Adolescents Following Bullying-Triggered Stress: A Dual Case Report. · Full Atlas view
- Prolonged Catatonia and Severe Malnutrition in Adolescents Following Bullying-Triggered Stress: A Dual Case Report. · Full Atlas view
- Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. · Full Atlas view
- Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression · Full Atlas view
- Prophylactic effect of valproate in the treatment for siblings with catatonia: a case report. · Full Atlas view
- Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression · Full Atlas view
- Prospective Study of Different Diagnostic Criteria for Catatonia and Delirium in Internal Medicine and Neurology Admissions. · Full Atlas view
- Prospective Study of Different Diagnostic Criteria for Catatonia and Delirium in Internal Medicine and Neurology Admissions. · Full Atlas view
- Prospective Treatment Study of Catatonia Patients · Full Atlas view
- Prospective alcohol and PTSD follow-up in veterans · Full Atlas view
- Prospective case series in combat veterans · Full Atlas view
- Prospective nine-patient series · Full Atlas view
- Psilocybin Cancer Anxiety Study · Full Atlas view
- Psilocybin Therapy for Depression in Bipolar II Disorder · Full Atlas view
- Psilocybin Versus Ketamine in Treatment-Resistant Depression · Full Atlas view
- Psilocybin and Depression · Full Atlas view
- Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD) · Full Atlas view
- Psilocybin and heavy drinking days · Full Atlas view
- Psilocybin for Treatment of Obsessive Compulsive Disorder · Full Atlas view
- Psilocybin in Depression Resistant to Standard Treatments · Full Atlas view
- Psilocybin in cocaine use disorder · Full Atlas view
- Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial · Full Atlas view
- Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder · Full Atlas view
- Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study · Full Atlas view
- Psilocybin-facilitated Treatment for Cocaine Use · Full Atlas view
- Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis. · Full Atlas view
- Psychiatric autoimmune conditions in children and adolescents: Is catatonia a severity marker? · Full Atlas view
- Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity. · Full Atlas view
- Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity. · Full Atlas view
- Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. · Full Atlas view
- Psychopharmacology of Psilocybin in Cancer Patients · Full Atlas view
- Psychoses by Attacks from Subverted Mast Cells: A Role for Arterial Intramural Flow Badly Steered by the Nasal Ganglia? · Full Atlas view
- Psychosis after ayahuasca · Case and follow-up · Full Atlas view
- Psychosis and catatonia in fragile X: Case report and literature review. · Full Atlas view
- Psychosis and catatonia in fragile X: Case report and literature review. · Full Atlas view
- Psychosis and catatonia in fragile X: Case report and literature review. · Full Atlas view
- Psychosis in the ED: A case of NMDA receptor antibody encephalitis. · Full Atlas view
- Psychosis with catatonic features after repeated use · Full Atlas view
- Psychosis, Catatonia and Tachypnoea Following Paliperidone Palmitate 3-Monthly Injection Error: Case Report. · Full Atlas view
- Psychosis, Catatonia and Tachypnoea Following Paliperidone Palmitate 3-Monthly Injection Error: Case Report. · Full Atlas view
- Psychosis, Catatonia and Tachypnoea Following Paliperidone Palmitate 3-Monthly Injection Error: Case Report. · Full Atlas view
- Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation · Full Atlas view
- PubMed 15734224 · Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Depend. 2005 Mar 7;77(3):243-9. doi: 10.1016/j.drugalcdep.2004.08.016. · Full Atlas view
- PubMed 17196053 · Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006 Nov;67(11):1735-40. doi: 10.4088/jcp.v67n1110. · Full Atlas view
- PubMed 25563446 · Winkelman M. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Curr Drug Abuse Rev. 2014;7(2):101-16. doi: 10.2174/1874473708666150107120011. · Full Atlas view
- PubMed 25586396 · Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015 Mar;29(3):289-99. doi: 10.1177/0269881114565144. Epub 2015 Jan 13. · Full Atlas view
- PubMed 25784600 · Bogenschutz MP, Johnson MW. Classic hallucinogens in the treatment of addictions. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14. · Full Atlas view
- PubMed 25818246 · Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:237-49. doi: 10.1016/j.pnpbp.2015.03.011. Epub 2015 Mar 25. · Full Atlas view
- PubMed 27010975 · Danovitch I. Post-traumatic stress disorder and opioid use disorder: A narrative review of conceptual models. J Addict Dis. 2016 Jul-Sep;35(3):169-79. doi: 10.1080/10550887.2016.1168212. Epub 2016 Mar 24. · Full Atlas view
- PubMed 30091969 · Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr.mm6731a1. · Full Atlas view
- PubMed 30196397 · Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology (Berl). 2018 Nov;235(11):3137-3148. doi: 10.1007/s00213-018-5010-9. Epub 2018 Sep 8. · Full Atlas view
- PubMed 30572160 · Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA, Dale RM, Hu B, Krishnan K, Kellner CH, Malone DA, Murrough JW, Ostroff RB, Sanacora G, Shao M, Anand A. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol. Contemp Clin Trials. 2019 Feb;77:19-26. doi: 10.1016/j.cct.2018.12.009. Epub 2018 Dec 17. · Full Atlas view
- PubMed 30944474 · Nardou R, Lewis EM, Rothhaas R, Xu R, Yang A, Boyden E, Dolen G. Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature. 2019 May;569(7754):116-120. doi: 10.1038/s41586-019-1075-9. Epub 2019 Apr 3. · Full Atlas view
- PubMed 31065731 · Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology (Berl). 2019 Sep;236(9):2735-2745. doi: 10.1007/s00213-019-05249-5. Epub 2019 May 7. · Full Atlas view
- PubMed 31231276 · de Almeida RN, Galvao ACM, da Silva FS, Silva EADS, Palhano-Fontes F, Maia-de-Oliveira JP, de Araujo LB, Lobao-Soares B, Galvao-Coelho NL. Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial. Front Psychol. 2019 Jun 4;10:1234. doi: 10.3389/fpsyg.2019.01234. eCollection 2019. · Full Atlas view
- PubMed 31681040 · Meulewaeter F, De Pauw SSW, Vanderplasschen W. Mothering, Substance Use Disorders and Intergenerational Trauma Transmission: An Attachment-Based Perspective. Front Psychiatry. 2019 Oct 18;10:728. doi: 10.3389/fpsyt.2019.00728. eCollection 2019. · Full Atlas view
- PubMed 31916890 · Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponte KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol. 2020 Feb;34(2):155-166. doi: 10.1177/0269881119897615. Epub 2020 Jan 9. · Full Atlas view
- PubMed 32098487 · Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. · Full Atlas view
- PubMed 33601929 · Sessa B, Higbed L, O'Brien S, Durant C, Sakal C, Titheradge D, Williams TM, Rose-Morris A, Brew-Girard E, Burrows S, Wiseman C, Wilson S, Rickard J, Nutt DJ. First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. J Psychopharmacol. 2021 Apr;35(4):375-383. doi: 10.1177/0269881121991792. Epub 2021 Feb 18. · Full Atlas view
- PubMed 33626254 · Brannan SK, Sawchak S, Miller AC, Lieberman JA, Paul SM, Breier A. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia. N Engl J Med. 2021 Feb 25;384(8):717-726. doi: 10.1056/NEJMoa2017015. · Full Atlas view
- PubMed 33884617 · Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2. · Full Atlas view
- PubMed 33972795 · Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. · Full Atlas view
- PubMed 34412104 · Canuso CM, Ionescu DF, Li X, Qiu X, Lane R, Turkoz I, Nash AI, Lopena TJ, Fu DJ. Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior. J Clin Psychopharmacol. 2021 Sep-Oct 01;41(5):516-524. doi: 10.1097/JCP.0000000000001465. · Full Atlas view
- PubMed 34510411 · Dean RL, Hurducas C, Hawton K, Spyridi S, Cowen PJ, Hollingsworth S, Marquardt T, Barnes A, Smith R, McShane R, Turner EH, Cipriani A. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3. · Full Atlas view
- PubMed 34700212 · Targum SD, Murphy C, Breier A, Brannan SK. Site-independent confirmation of primary site-based PANSS ratings in a schizophrenia trial. J Psychiatr Res. 2021 Dec;144:241-246. doi: 10.1016/j.jpsychires.2021.10.027. Epub 2021 Oct 21. · Full Atlas view
- PubMed 34853114 · Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A. Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. BMJ Open. 2021 Dec 1;11(12):e056091. doi: 10.1136/bmjopen-2021-056091. · Full Atlas view
- PubMed 35552528 · Weiden PJ, Breier A, Kavanagh S, Miller AC, Brannan SK, Paul SM. Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study. J Clin Psychiatry. 2022 May 11;83(3):21m14316. doi: 10.4088/JCP.21m14316. · Full Atlas view
- PubMed 35816217 · Rozjabek H, Li N, Hartmann H, Fu DJ, Canuso C, Jamieson C. Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray. J Patient Rep Outcomes. 2022 Jul 10;6(1):74. doi: 10.1186/s41687-022-00453-y. · Full Atlas view
- PubMed 35904046 · Turkoz I, Lopena O, Salvadore G, Sanacora G, Shelton R, Fu DJ. Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE. CNS Spectr. 2023 Aug;28(4):482-488. doi: 10.1017/S1092852922000931. Epub 2022 Jul 29. · Full Atlas view